Nandrolone decanoate and resistance exercise training favor the occurrence of lesions and activate the inflammatory response in the ventral prostate

Andrology

Volumn 4, Issue 3, 2016, Pages 473-480

  Gomes, F C ^a   Chuffa, L G A ^a   Scarano, W R ^a   Pinheiro, P F F ^a   Favaro W J ^a,b   Domeniconi, Raquel Fantin ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Cytokines; Inflammation; Oxidative stress; Physical exercise; Prostate; Steroids

Indexed keywords

INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE P38; NANDROLONE DECANOATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; ANABOLIC AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NANDROLONE; NOX1 PROTEIN, RAT; TLR2 PROTEIN, RAT; TLR4 PROTEIN, RAT; TUMOR NECROSIS FACTOR;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; INFLAMMATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTATE TUMOR; PROSTATE VENTRAL LOBE; PROTEIN EXPRESSION; RAT; RESISTANCE TRAINING; SIGNAL TRANSDUCTION; UPREGULATION; ANALOGS AND DERIVATIVES; ANIMAL; DRUG EFFECTS; METABOLISM; PATHOLOGY; PROSTATE; SPRAGUE DAWLEY RAT;

ANABOLIC AGENTS; ANIMALS; INFLAMMATION; INTERLEUKIN-6; MALE; NADPH OXIDASE 1; NANDROLONE; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHYSICAL CONDITIONING, ANIMAL; PROSTATE; RATS; RATS, SPRAGUE-DAWLEY; RESISTANCE TRAINING; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84961807646     PISSN: 20472919     EISSN: 20472927     Source Type: Journal    
DOI: 10.1111/andr.12162     Document Type: Article

References (52)

1. Agrawal T, Bhengraj AR, Vats V & Mittal A. (2013) Chlamydia trachomatis: TLR4-mediated recognition by human dendritic cells is impaired following oestradiol treatment. Br J Biomed Sci 70, 51-57.
2. Akira S & Takeda K. (2004) Toll-like receptor signaling. Immunology 4, 499-511.
3. Balistreri CR, Colonna-Romano G, Lio D, Candore G & Caruso C. (2009) TLR4 polymorphisms and ageing: implications for the pathophysiology of age-related diseases. J Clin Immunol 29, 406-415.
4. Bedard K & Krause KH. (2007) The NOX family of ROS-Generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 87, 245-313.
5. Bedard K, Lardy B & Krause KH. (2007) NOX family NADPH oxidases: not just in mammals. Biochimie 89, 1107-1112.
6. Bonetti A, Tirelli F, Catapano A, Dazzi D, Dei Cas A, Solito F, Ceda G, Reverberi C, Monica C, Pipitone S, Elia G, Spattini M & Magnati G. (2008) Side effects of anabolic androgenic steroids abuse. Int J Sports Med 29, 679-687.
7. Bradford MM. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 72, 248-254.
8. Brogårdh C & Lexell J. (2012) Effects of cardiorespiratory fitness and muscle-resistance training after stroke. Exerc Sports Health Promot Dis Disabil 4, 901-907.
9. Chung T, Kelleher S, Liu PY, Conway AJ, Kritharides L & Handelsman DJ. (2007) Effects of testosterone and nandrolone on cardiac function: a randomized, placebo-controlled study. Clin Endocrinol 66, 235-245.
10. Clark AS, Harrold EV & Fast AS. (1997) Anabolic-androgenic steroid effects on the sexual behavior of intact male rats. Horm Beha 31, 35-46.
11. De Melo Neto JS, de Campos Gomes F, Pinheiro PFF, Pereira S, Scarano WR, Fávaro WJ & Domeniconi RF. (2015) The effects of high doses of nandrolone decanoate and exercise on prostate microvasculature of adult and older rats. Life Sci 121, 16-21.
12. Dohle GR, Smit M & Weber RF. (2003) Androgens and male fertility. World J Urol 21, 341-345.
13. Ellem SJ & Risbridger GP. (2010) Aromatase and regulating the estrogen: androgen ratio in the prostate gland. J Steroid Biochem Mol Biol 118, 246-251.
14. Erridge C. (2010) Endogenous ligands of TLR2 and TLR4: agonists or assistants? J Leukoc Biol 87, 989-999.
15. Finaud J, Lac G & Filaire E. (2006) Oxidative stress: relationship with exercise and training. Sports Med 36, 327-358.
16. Franquni JV, Do Nascimento AM, De Lima EM, Brasil GA, Heringer OA, Cassaro KO, Da Cunha TV, Musso C, Silva Santos MC, Kalil IC, Endringer DC, Boëchat GA, Bissoli NS & De Andrade TU. (2013) Nandrolone decanoate determines cardiac remodelling and injury by an imbalance in cardiac inflammatory cytokines and ACE activity, blunting of the Bezold-Jarisch reflex, resulting in the development of hypertension. Steroids 78, 379-385.
17. Friedenreich CM, Neilson HK & Lynch BM. (2010) State of the epidemiological evidence on physical activity and cancer prevention. Eur J Cancer 46, 2593-2604.
18. González-Reyes S, Marín L, González L, González LO, Del Casar JM, Lamelas ML, González-Quintana JM & Vizoso FJ. (2011) Study of TLR3, TLR4 and TLR9 in breast carcinomas and their association with metastasis. BMC Cancer 10, 2407-2410.
19. Gupte AA, Lyon CJ & Hsueh WA. (2013) Nuclear factor (erythroid-derived 2)-like-2 factor (Nrf2), a key regulator of the antioxidant response to protect against atherosclerosis and nonalcoholic steatohepatitis. Curr Diab Rep 13, 362-371.
20. Hackney AC. (2001) Endurance exercise training and reproductive endocrine dysfunction in men: alterations in the hypothalamic-pituitary-testicular axis. Curr Pharm Des 7, 261-273.
21. Jungi TW, Farhat K, Burgener IA & Werling D. (2011) Toll-like receptors in domestic animals. Cell Tissue Res 343, 107-120.
22. Kant S, Swat W, Zhang S, Zhang ZY, Neel BG, Flavell RA & Davis RJ. (2011) TNF-stimulated MAP kinase activation mediated by a Rho family GTPase signaling pathway. Genes Dev 25, 2069-2078.
23. Kawai T & Akira S. (2007) TLR signaling. Semin Immunol 19, 24-32.
24. Khandrika L, Kumar B, Koul S, Maroni P & Kou HK. (2009) Oxidative stress in prostate cancer. Cancer Lett 21, 125-136.
25. Kim J, Cha YN & Surh YJ. (2010) A protective role of nuclear factor-erythroid 2-related factor-2 (Nrf2) in inflammatory disorders. Mutat Res 7, 12-23.
26. Koul HK, Pal M & Koul S. (2013) Role of p38 MAP kinase signal transduction in solid tumors. Genes Cancer 4, 342-359.
27. Kramer G, Mitteregger D & Marberger M. (2007) Is benign prostatic hyperplasia (BPH) an immune inflammatory disease? Eur Urol 51, 1202-1216.
28. Kruk J & Czerniak U. (2013) Physical activity and its relation to cancer risk: updating the evidence. Asian Pac J Cancer Prev 14, 3993-4003.
29. Lee CH, Jeon YT, Kim SH & Song YS. (2007) NF-κB as a potential molecular target for câncer therapy. BioFactors 29, 19-35.
30. Leimgruber C, Quintar AA, García LN, Petiti JP, De Paul AL & Maldonado CA. (2013) Testosterone abrogates TLR4 activation in prostate smooth muscle cells contributing to the preservation of a differentiated phenotype. J Cell Physiol 7, 1551-1560.
31. Liu TC, Kuo CH & Wang PS. (2009) Exercise and testosterone. Adapt Med 1, 26-31.
32. Longbiao Z, Hua Y & Tao J. (2013) Association of TLR2 and TLR4 polymorphisms with risk of cancer: a meta-analysis. PLoS ONE 8, 1-9.
33. Lorne E, Dupont H & Abraham E. (2010) Toll-like receptors 2 and 4: initiators of non-septic inflammation in critical care medicine? Intensive Care Med 36, 1826-1835.
34. McCarthy CG, Goulopoulou S, Wenceslau CF, Spitler K, Matsumoto T & Webb RC. (2014) Toll-like receptors and damage-associated molecular patterns: novel links between inflammation and hypertension. Am J Physiol Heart Circ Physiol 306, H184-H196.
35. McCubrey JA, Lahair MM & Franklin RA. (2006) Reactive oxygen species-induced activation of the MAP kinase signaling pathways. Antioxid Redox Signal 8, 1775-1789.
36. Mullgan K & Schambelan M. (2002) Anabolic treatment with GH, IGF-I, or anabolic steroids in patients with HIV-associated wasting. Int J Cardiol 85, 151-159.
37. Nieman DC, Davis JM, Brown VA, Henson DA, Dumke CL, Utter AC, Vinci DM, Downs MF, Smith JC, Carson J, Brown A, McAnulty SR & McAnulty LS. (2004) Influence of carbohydrate ingestion on immune changes after 2 h of intensive resistance training. J Appl Physiol 96, 1292-1298.
38. Palsson-McDermott EM, Doyle SL, McGettrick AF, Hardy M, Husebye H, Banahan K, Gong M, Golenbock D, Espevik T & O'Neill LA. (2009) TAG, a splice variant of the adaptor TRAM, negatively regulates the adaptor MyD88-independent TLR4 pathway. Nat Immunol 10, 579-586.
39. Pedersen BK & Hoffman-Goetz L. (2000) Exercise and the immune system: regulation, integration, and adaptation. Physiol Rev 80, 1055-1081.
40. Pendyala S & Natarajan V. (2010) Redox regulation of Nox proteins. Respir Physiol Neurobiol 174, 265-271.
41. Pope HG, Jr & Katz DL. (1988) Affective and psychotic symptoms associated with anabolic steroid use. Am J Psychiatry 145, 487-490.
42. Pradere JP, Dapito DH & Schwabe RF. (2013) The Yin and Yang of toll-like receptors in cancer. Oncogene 12, 3485-3495.
43. Quintar AA, Roth FD, De Paul AL, Aoki A & Maldonado CA. (2006) Toll-like receptor 4 in rat prostate: modulation by testosterone and acute bacterial infection in epithelial and stromal cells. Biol Reprod 75, 664-672.
44. Rebillard A, Lefeuvre-Orfila L, Gueritat J & Cillard J. (2013) Prostate cancer and physical activity: adaptive response to oxidative stress. Free Radic Biol Med J 60, 115-124.
45. Ricote M, Royuela M, García-Tuñón I, Bethencourt FR, Paniagua R & Fraile B. (2003) Pro-apoptotic tumor necrosis factor-alpha transduction pathway in normal prostate, benign prostatic hyperplasia and prostatic carcinoma. J Urol 3, 787-790.
46. Scheller J, Chalaris A, Schmidt-Arras D & Rose-John S. (2011) The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim Biophys Acta 5, 878-888.
47. Shappell SB, Thomas GV, Roberts RL, Herbert R, Ittmann MM, Rubin MA, Humphrey PA, Sundberg JP, Rozengurt N, Barrios R, Ward JM & Cardiff RD. (2004) Prostate pathology of genetically engineered mice: definitions and classification. The consensus report from the Bar Harbor Meeting of the mouse models of human cancer consortium prostate pathology committee. Cancer Res 64, 2270-2305.
48. Shokri S, Aitken RJ, Abdolvahhabi M, Abolhasani F, Ghasemi FM, Kashani I, Ejtemaeimehr S, Ahmadian S, Minaei B, Naraghi MA & Barbarestani M. (2010) Exercise and supraphysiological dose of nandrolone decanoate increase apoptosis in spermatogenic cells. Basic Clin Pharmacol Toxicol 106, 324-330.
49. Sin WX, Li P, Yeong JP & Chin KC. (2012) Activation and regulation of interferon-β in immune responses. Immunol Res 53, 25-40.
50. Skeldon SC & Goldenberg SL. (2014) Urological complications of illicit drug use. Nat Rev Urol 11, 169-177.
51. Sumimoto H, Miyano K & Takeya R. (2005) Molecular composition and regulation of the Nox Family NAD(P)H oxidases. Biochem Biophys Res Commun 338, 677-686.
52. Suzuki K, Nakaji S, Yamada M, Totsuka M, Sato K & Sugawara K. (2002) Systemic inflammatory response to exhaustive exercise. Cytokine kinetics. Exerc Immunol 8, 6-48.